Osaic Holdings’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $798K | Buy |
2,696
+1,067
| +66% | +$316K | ﹤0.01% | 2402 |
|
|
2025
Q1 | $440K | Sell |
1,629
-3,200
| -66% | -$864K | ﹤0.01% | 2992 |
|
|
2024
Q4 | $417K | Buy |
4,829
+3,465
| +254% | +$299K | ﹤0.01% | 2956 |
|
|
2024
Q3 | $375K | Buy |
1,364
+174
| +15% | +$47.9K | ﹤0.01% | 3136 |
|
|
2024
Q2 | $289K | Sell |
1,190
-373
| -24% | -$90.6K | ﹤0.01% | 3252 |
|
|
2024
Q1 | $234K | Sell |
1,563
-2,032
| -57% | -$304K | ﹤0.01% | 3559 |
|
|
2023
Q4 | $688K | Sell |
3,595
-625
| -15% | -$120K | ﹤0.01% | 2880 |
|
|
2023
Q3 | $747K | Buy |
4,220
+182
| +5% | +$32.2K | ﹤0.01% | 2893 |
|
|
2023
Q2 | $772K | Buy |
4,038
+284
| +8% | +$54.3K | ﹤0.01% | 2749 |
|
|
2023
Q1 | $754K | Sell |
3,754
-2,301
| -38% | -$462K | ﹤0.01% | 2749 |
|
|
2022
Q4 | $1.44M | Buy |
6,055
+2,851
| +89% | +$677K | ﹤0.01% | 2020 |
|
|
2022
Q3 | $641K | Sell |
3,204
-1,654
| -34% | -$331K | ﹤0.01% | 2640 |
|
|
2022
Q2 | $709K | Sell |
4,858
-825
| -15% | -$120K | ﹤0.01% | 2601 |
|
|
2022
Q1 | $850K | Sell |
5,683
-165
| -3% | -$24.7K | ﹤0.01% | 2727 |
|
|
2021
Q4 | $994K | Buy |
5,848
+418
| +8% | +$71K | ﹤0.01% | 2410 |
|
|
2021
Q3 | $1.03M | Buy |
5,430
+262
| +5% | +$49.5K | ﹤0.01% | 2324 |
|
|
2021
Q2 | $876K | Buy |
5,168
+604
| +13% | +$102K | ﹤0.01% | 2485 |
|
|
2021
Q1 | $643K | Buy |
4,564
+2,313
| +103% | +$326K | ﹤0.01% | 2618 |
|
|
2020
Q4 | $292K | Buy |
2,251
+234
| +12% | +$30.4K | ﹤0.01% | 3139 |
|
|
2020
Q3 | $292K | Buy |
2,017
+333
| +20% | +$48.2K | ﹤0.01% | 2901 |
|
|
2020
Q2 | $247K | Buy |
1,684
+235
| +16% | +$34.5K | ﹤0.01% | 2935 |
|
|
2020
Q1 | $159K | Buy |
+1,449
| New | +$159K | ﹤0.01% | 3080 |
|